Submitted by Anonymous (not verified) on 11 July 2025 - 15:32
Human medicines European public assessment report (EPAR): Idacio, adalimumab, Date of authorisation: 02/04/2019, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Idacio, adalimumab, Date of authorisation: 02/04/2019, Revision: 13, Status: Authorised